188 related articles for article (PubMed ID: 36711890)
1. Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer.
Yan W; Steele NG; Kemp SB; Menjivar RE; Du W; Carpenter ES; Donahue KL; Brown KL; Irizarry-Negron V; Yang S; Burns WR; Zhang Y; di Magliano MP; Bednar F
bioRxiv; 2023 Jan; ():. PubMed ID: 36711890
[TBL] [Abstract][Full Text] [Related]
2. Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer.
Yan W; Menjivar RE; Bonilla ME; Steele NG; Kemp SB; Du W; Donahue KL; Brown KL; Carpenter ES; Avritt FR; Irizarry-Negron VM; Yang S; Burns WR; Zhang Y; Pasca di Magliano M; Bednar F
Cancer Immunol Res; 2024 Jan; 12(1):91-106. PubMed ID: 37931247
[TBL] [Abstract][Full Text] [Related]
3. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelin synthase 2 is a positive regulator of the CSF1R-STAT3 pathway in pancreatic cancer-associated macrophage.
He S; Gu X; Yang J; Xu F; Hu J; Wang W; Huang Y; Lou B; Ding T; Zhou L; Ye D; Yu K; Dong J
Front Pharmacol; 2022; 13():902016. PubMed ID: 36324684
[No Abstract] [Full Text] [Related]
5. Arginase 1 is a key driver of immune suppression in pancreatic cancer.
Menjivar RE; Nwosu ZC; Du W; Donahue KL; Hong HS; Espinoza C; Brown K; Velez-Delgado A; Yan W; Lima F; Bischoff A; Kadiyala P; Salas-Escabillas D; Crawford HC; Bednar F; Carpenter E; Zhang Y; Halbrook CJ; Lyssiotis CA; Pasca di Magliano M
Elife; 2023 Feb; 12():. PubMed ID: 36727849
[TBL] [Abstract][Full Text] [Related]
6. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
7. Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism.
Jiang H; Courau T; Borison J; Ritchie AJ; Mayer AT; Krummel MF; Collisson EA
Gastroenterology; 2022 Feb; 162(2):590-603.e14. PubMed ID: 34627860
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling pathway in pancreatic tumorigenesis.
Chung WC; Xu K
Adv Cancer Res; 2023; 159():1-36. PubMed ID: 37268393
[TBL] [Abstract][Full Text] [Related]
9. The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus dual checkpoint inhibition maintains antitumor immune cells.
Rana M; Kansal R; Chaib M; Teng B; Morrrison M; Hayes DN; Stanfill AG; Shibata D; Carson JA; Makowski L; Glazer ES
Mol Carcinog; 2022 Jun; 61(6):549-557. PubMed ID: 35319799
[TBL] [Abstract][Full Text] [Related]
10. VentX expression in tumor-associated macrophages promotes phagocytosis and immunity against pancreatic cancers.
Le Y; Gao H; Richards W; Zhao L; Bleday R; Clancy T; Zhu Z
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573491
[TBL] [Abstract][Full Text] [Related]
11. Targeting TNF-α-producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling.
Dixit A; Sarver A; Zettervall J; Huang H; Zheng K; Brekken RA; Provenzano PP
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36256464
[TBL] [Abstract][Full Text] [Related]
12. Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF-PI3K pathway.
Boyer S; Lee HJ; Steele N; Zhang L; Sajjakulnukit P; Andren A; Ward MH; Singh R; Basrur V; Zhang Y; Nesvizhskii AI; Pasca di Magliano M; Halbrook CJ; Lyssiotis CA
Elife; 2022 Feb; 11():. PubMed ID: 35156921
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.
Daniel SK; Sullivan KM; Labadie KP; Pillarisetty VG
Clin Transl Med; 2019 Apr; 8(1):10. PubMed ID: 30931508
[TBL] [Abstract][Full Text] [Related]
14. Notch Signaling in Macrophages in the Context of Cancer Immunity.
Palaga T; Wongchana W; Kueanjinda P
Front Immunol; 2018; 9():652. PubMed ID: 29686671
[TBL] [Abstract][Full Text] [Related]
15. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.
Liu H; Wang J; Zhang M; Xuan Q; Wang Z; Lian X; Zhang Q
Breast Cancer Res Treat; 2017 Nov; 166(1):95-107. PubMed ID: 28730338
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
17. Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase.
Weizman N; Krelin Y; Shabtay-Orbach A; Amit M; Binenbaum Y; Wong RJ; Gil Z
Oncogene; 2014 Jul; 33(29):3812-9. PubMed ID: 23995783
[TBL] [Abstract][Full Text] [Related]
18. Siglec-15 Regulates the Inflammatory Response and Polarization of Tumor-Associated Macrophages in Pancreatic Cancer by Inhibiting the cGAS-STING Signaling Pathway.
Li H; Zhu R; Liu X; Zhao K; Hong D
Oxid Med Cell Longev; 2022; 2022():3341038. PubMed ID: 36105484
[TBL] [Abstract][Full Text] [Related]
19. Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease.
Hutcheson J; Balaji U; Porembka MR; Wachsmann MB; McCue PA; Knudsen ES; Witkiewicz AK
Clin Cancer Res; 2016 Jul; 22(14):3606-17. PubMed ID: 26858311
[TBL] [Abstract][Full Text] [Related]
20. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ
Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
